Table 2 Incidence rates and hazard ratios (HRs) for associations of fracture with exposure to polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)

 Overall

1689

148.05 (141.16–155.28)

5173

115.67 (112.56–118.87)

1.29 (1.22–1.36)

1.63 (1.54–1.73)

 Male

244

68.79 (60.68–77.99)

707

52.07 (48.37–56.06)

1.32 (1.15–1.53)

1.54 (1.33–1.81)

 Female

1445

183.81 (174.57–193.54)

4466

143.4 (139.25–147.67)

1.29 (1.22–1.37)

1.61 (1.52–1.72)

 40–50

16

45.58 (27.93–74.41)

48

32.55 (24.53–43.2)

1.40 (0.81–2.41)

1.92 (1.01–3.69)

 50–60

116

81.29 (67.77–97.52)

264

46.04 (40.81–51.94)

1.78 (1.43–2.2)

2.23 (1.79–2.79)

 60–70

357

112.33 (101.26–124.61)

1018

78.56 (73.88–83.53)

1.44 (1.28–1.62)

1.85 (1.56–2.10)

 70–80

753

161.12 (150.01–173.04)

2555

138.51 (133.25–143.99)

1.17 (1.08–1.26)

1.51 (1.38–1.64)

  ≥ 80

447

251.34 (229.08–275.75)

1288

210.89 (199.68–222.72)

1.21 (1.08–1.34)

1.61 (1.43–1.81)

 Overall

371

147.15 (132.91–162.91)

1142

109.52 (103.35–116.06)

1.36 (1.22–1.53)

1.67 (1.49–1.88)

 Male

49

66.62 (50.35–88.15)

127

42.37 (35.61–50.42)

1.59 (1.15–2.2)

1.62 (1.17–2.24)

 Female

322

180.31 (161.66–201.12)

1015

136.6 (128.45–145.27)

1.34 (1.19–1.51)

1.67 (1.47–1.90)

 40–50

4

35.23 (13.22–93.86)

9

18.87 (9.82–36.26)

1.87 (0.63–5.58)

1.98 (0.66–5.94)

 50–60

18

55.2 (34.78–87.61)

46

34.94 (26.17–46.65)

1.56 (0.9–2.71)

2.27 (1.25–4.15)

 60–70

85

112.74 (91.15–139.45)

257

78.19 (69.19–88.36)

1.49 (1.17–1.89)

1.79 (1.40–2.30)

 70–80

181

185.8 (160.61–214.94)

579

141.96 (130.85–154)

1.34 (1.13–1.57)

1.65 (1.39–1.95)

  ≥ 80

83

234.75 (189.31–291.1)

251

197.88 (174.85–223.94)

1.20 (0.93–1.54)

1.48 (1.13–1.94)